UCLA Pharmaceutical Economics and Policy

Program Objective: This program promotes teaching and research on issues related to pharmaceuticals and the pharmaceutical industry. It trains professionals seeking careers in the area, and supports the work of industry and government.

William S. Comanor

Associate Directors:
Stuart O. Schweitzer
Michael O. Intriligator

Telephone:  (310) 206-1641
Fax:  (310) 825-3317


Upcoming Schedule

All meetings are held in the Brentwood Room, 16-154 CHS on Thursday afternoons from 4:30 PM - 6:30 PM.  There will be dinner with the speaker at the UCLA Faculty Center following the Seminar.

October 6, 2016
William S. Comanor
Title: “An Introduction to the Economics of the Pharmaceutical Industry”

October 13, 2016
Ernst Berndt
Sloan School of Management, MIT
Title: “Prescription Drug Spending in the US: Is the Era of Slow Growth Over?”

November 3, 2016
Harry First
New York University School of Law
Title: "Unfair Drug Prices and Section 5 of the FTC Act”

November 17, 2016
Joel Hay
Title: “Effects of Health Plan Mergers on Drug Prices”

December 1, 2016
F.M. Scherer
Kennedy School of Government, Harvard University
Title: "The Diffusion of AIDS Drugs into Low Income Countries: A Retrospective”

January 12, 2017
Steve Miller
Chief Medical Officer, Express Scripts, Inc.
Title: "Unlocking the Black Box: Negotiations between PBMs and Pharma over Rebates"

January 26, 2017
Tomas Philipson
Harris School of Public Policy, University of Chicago
Title: "Financial Health Economics: Implications for Biopharmaceuticals"

February 9, 2017
Anita Rao
Booth School of Business, University of Chicago
Title: "Strategic R&D Investment Decisions in the Pharmaceutical Industry"

February 23, 2017
Jack Needleman
UCLA Fielding School of Public Health 
Title: "Are Generic Drug Prices Too Low?" 

March 9, 2017
Stuart O. Schweitzer 
UCLA Fielding School of Public Health 
Title: "Conflicting Goals in Payments for Hepatitis C Drugs" 

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer